BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27773935)

  • 1. Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation.
    Meng Q; Duan XP; Wang CY; Liu ZH; Sun PY; Huo XK; Sun HJ; Peng JY; Liu KX
    Acta Pharmacol Sin; 2017 Jan; 38(1):69-79. PubMed ID: 27773935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
    Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice.
    Wang C; Duan X; Sun X; Liu Z; Sun P; Yang X; Sun H; Liu K; Meng Q
    Food Funct; 2016 Sep; 7(9):3716-23. PubMed ID: 27487733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice.
    Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Yao J; Liu K
    Pharm Res; 2015 Nov; 32(11):3688-98. PubMed ID: 26040663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alisol B 23-acetate promotes liver regeneration in mice after partial hepatectomy via activating farnesoid X receptor.
    Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Peng J; Liu K
    Biochem Pharmacol; 2014 Nov; 92(2):289-98. PubMed ID: 25278094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of alisol B 23-acetate from edible botanical Rhizoma alismatis against carbon tetrachloride-induced hepatotoxicity in mice.
    Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Liu K
    Food Funct; 2015 Apr; 6(4):1241-50. PubMed ID: 25747392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    Zhang S; Wang J; Liu Q; Harnish DC
    J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
    Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
    Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.
    Dong R; Yang X; Wang C; Liu K; Liu Z; Ma X; Sun H; Huo X; Fu T; Meng Q
    Phytomedicine; 2019 Feb; 53():134-142. PubMed ID: 30668392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alisol A 24-acetate ameliorates nonalcoholic steatohepatitis by inhibiting oxidative stress and stimulating autophagy through the AMPK/mTOR pathway.
    Wu C; Jing M; Yang L; Jin L; Ding Y; Lu J; Cao Q; Jiang Y
    Chem Biol Interact; 2018 Aug; 291():111-119. PubMed ID: 29883724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
    Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
    Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosis.
    Fu Y; Feng H; Ding X; Meng QH; Zhang SR; Li J; Chao Y; Ji TT; Bi YH; Zhang WW; Chen Q; Zhang YH; Feng YL; Bian HM
    Phytomedicine; 2022 Jul; 101():154120. PubMed ID: 35523117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of estrogen receptor α (ERα) is required for Alisol B23-acetate to prevent post-menopausal atherosclerosis and reduced lipid accumulation.
    Chen Q; Chao Y; Zhang W; Zhang Y; Bi Y; Fu Y; Cai D; Meng Q; Li Y; Bian H
    Life Sci; 2020 Oct; 258():118030. PubMed ID: 32739470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The probiotic effects of AB23A on high-fat-diet-induced non-alcoholic fatty liver disease in mice may be associated with suppressing the serum levels of lipopolysaccharides and branched-chain amino acids.
    Xia F; Xiang S; Chen Z; Song L; Li Y; Liao Z; Ge B; Zhou B
    Arch Biochem Biophys; 2021 Dec; 714():109080. PubMed ID: 34742934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
    Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
    FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation.
    Wang X; Fu T; Wang J; Wang C; Liu K; Wu J; Sun H; Ma X; Sun P; Meng Q
    Int Immunopharmacol; 2019 Oct; 75():105833. PubMed ID: 31450152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical study of alisol B 23-acetate on methionine and choline deficient diet-induced nonalcoholic steatohepatitis based on untargeted metabolomics.
    Li HJ; Wang YS; Wang YN; Liu AR; Su XH; Ma ZA; Wang LX; Zhang ZY; Lv SQ; Miao J; Cui HT
    Biomed Chromatogr; 2024 Jan; 38(1):e5763. PubMed ID: 37858975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
    Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
    J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.